Real-world treatment patterns and total cost of care in Medicare patients with metastatic pancreatic ductal adenocarcinoma who received first-line FOLFIRINOX

被引：0
|
作者：
Hirsch, Jared
Cockrum, Paul
Tomicki, Samantha
Dieguez, Gabriela
Bhatt, Prachi
Kim, George P.
机构：
[1] Milliman Inc, New York, NY USA
[2] Ipsen Biopharmaceut Inc, Crowley, TX USA
[3] George Washington Univ, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16283
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The Efficacy of Liposomal Irinotecan Plus Fluorouracil/Leucovorin as First-Line Therapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma A Single-Center Real-World Study
    Chiang, Cho-Han
    Chiang, Cho-Hung
    Chiang, Cho-Hsien
    Chiu, Jing-Huey
    Ma, Kevin Sheng-Kai
    Chen, Brian Shiian
    Luan, Yu-Ze
    Cheng, Teng-Chieh
    Hsieh, Ching-Lung
    Peng, Cheng-Ming
    PANCREAS, 2022, 51 (08) : E107 - E109
  • [42] Second-line treatment with modified FOLFIRINOX in patients with pancreatic adenocarcinoma who have failed first-line treatment with gemcitabine and nab-paclitaxel
    McSweeney, T.
    Das, A.
    O'Mahony, A.
    O'Tighearnaigh, F.
    O'Byrne, L.
    Feely, M.
    Passmore, E.
    Keane, S.
    Lanigan, S.
    Fitzgerald, S.
    Browne, T.
    De Beer, V.
    Dean, A.
    ANNALS OF ONCOLOGY, 2023, 34 : S133 - S133
  • [43] REAL-WORLD HEALTHCARE RESOURCE UTILIZATION AND TOTAL COST OF CARE AMONG US MEDICARE PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA RECEIVING FIRST-LINE IBRUTINIB VS CHEMOIMMUNOTHERAPY
    Huang, Q.
    Emond, B.
    Lafeuille, M. H.
    Gupta, D.
    Lefebvre, P.
    Sundaram, M.
    Mato, A.
    VALUE IN HEALTH, 2020, 23 : S44 - S45
  • [44] Real-world biomarker testing and first-line treatment patterns among locally advanced, unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma patients in the US.
    Wellen, Maria
    Luu, Tony
    Gleason, Michelle Kathleen
    Majer, Istvan Matyas
    Reading, Stephanie Rummans
    JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (4_SUPPL) : 348 - 348
  • [45] Real-world first-line treatment patterns and outcomes in patients with locally advanced or metastatic urothelial carcinoma in the United States.
    Chen, Ronald C.
    Mucha, Lisa
    Nimke, David
    Young, Christopher
    Yang, Hongbo
    Liu, Qing
    Greatsinger, Alexandra
    Zhang, Adina
    Wright, Phoebe
    Quicquaro, Christina Marie
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [46] REAL-WORLD "CHAIR-TIME" BURDEN ASSOCIATED WITH INTRAVENOUS TREATMENT REGIMENS FOR PATIENTS WITH METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
    MacEwan, J.
    Surinach, A.
    Lamarre, N.
    Cockrum, P.
    VALUE IN HEALTH, 2022, 25 (07) : S326 - S326
  • [47] Real-world patterns of care among patients with metastatic pancreatic cancer (mPC)
    O'Reilly, Eileen Mary
    Surinach, Andy
    Wu, Zheng
    Cockrum, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [48] Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy
    Chikashi Yoshida
    Takeshi Kondo
    Tomoki Ito
    Masahiro Kizaki
    Kazuhiko Yamamoto
    Toshihiro Miyamoto
    Yasuyoshi Morita
    Tetsuya Eto
    Yuna Katsuoka
    Naoki Takezako
    Nobuhiko Uoshima
    Kazunori Imada
    Jun Ando
    Takuya Komeno
    Akio Mori
    Yuichi Ishikawa
    Atsushi Satake
    Junichi Watanabe
    Yoshiko Kawakami
    Tetsuo Morita
    Ikue Taneike
    Masahiko Nakayama
    Yinghui Duan
    Belen Garbayo Guijarro
    Alexander Delgado
    Cynthia Llamas
    Hitoshi Kiyoi
    International Journal of Hematology, 2022, 116 : 89 - 101
  • [49] Real-world treatment patterns and clinical outcomes in patients with AML in Japan who were ineligible for first-line intensive chemotherapy
    Yoshida, Chikashi
    Kondo, Takeshi
    Ito, Tomoki
    Kizaki, Masahiro
    Yamamoto, Kazuhiko
    Miyamoto, Toshihiro
    Morita, Yasuyoshi
    Eto, Tetsuya
    Katsuoka, Yuna
    Takezako, Naoki
    Uoshima, Nobuhiko
    Imada, Kazunori
    Ando, Jun
    Komeno, Takuya
    Mori, Akio
    Ishikawa, Yuichi
    Satake, Atsushi
    Watanabe, Junichi
    Kawakami, Yoshiko
    Morita, Tetsuo
    Taneike, Ikue
    Nakayama, Masahiko
    Duan, Yinghui
    Garbayo Guijarro, Belen
    Delgado, Alexander
    Llamas, Cynthia
    Kiyoi, Hitoshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 116 (01) : 89 - 101
  • [50] REAL-WORLD 30-DAY READMISSION PATTERNS AMONG COMMERCIALLY INSURED PATIENTS WITH METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA (MPDAC)
    Kim, G. P.
    Surinach, A.
    Cockrum, P.
    VALUE IN HEALTH, 2022, 25 (07) : S310 - S311
12345